Clark Capital Management Group, Inc.

Position in AMGN — Amgen Inc

CIK 1352187 PHILADELPHIA, PA

Position in AMGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$588,807

+$78,977 QoQ

Shares Held

1,626

+12.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#2,066

of 3,140 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Clark Capital Management Group, Inc. holds $673,709,624 across 9 Drug Manufacturers - General names. AMGN ranks #8 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	980,465	$249,008,696
2	LLY	ELI LILLY & Co	141,416	$169,618,607
3	AZN	Astrazeneca PLC	608,068	$115,301,854
4	MRK	Merck & Co., Inc.	652,471	$83,842,523
5	GILD	Gilead Sciences, Inc.	395,783	$50,003,224
6	ABBV	AbbVie Inc.	10,043	$2,527,220
7	NVS	Novartis AG	14,258	$2,234,513
8	AMGN	Amgen Inc This page	1,626	$588,807

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$588,807	1,626	+12.2%	Shares	Sole	2026-08-11
2026-03-31	$509,830	1,449	+9.2%	Shares	Sole	2026-05-15
2025-12-31	$434,340	1,327	+20.3%	Shares	Sole	2026-02-17
2025-09-30	$311,266	1,103	+19.8%	Shares	Sole	2025-11-14
2025-06-30	$257,152	921	-8.6%	Shares	Sole	2025-08-14
2025-03-31	$314,042	1,008	-20.2%	Shares	Sole	2025-05-15
2024-12-31	$329,188	1,263	-99.0%	Shares	Sole	2025-02-14
2024-09-30	$39,503,912	122,603	+2.0%	Shares	Sole	2024-11-14
2024-06-30	$37,569,300	120,241	+1.6%	Shares	Sole	2024-08-14
2024-03-31	$33,664,340	118,403	-43.3%	Shares	Sole	2024-05-15
2023-12-31	$60,178,322	208,938	+191.2%	Shares	Sole	2024-02-14
2020-09-30	$18,237,250	71,755	-4.5%	Shares	Sole	2020-11-12
2020-06-30	$17,724,879	75,150	-1.6%	Shares	Sole	2020-08-14
2020-03-31	$15,483,301	76,374	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.